The fusion between the ETS-related gene ERG and the transmembrane protease, serine 2 (TMPRSS2), has been found in approximately 50% of the PSA-screened prostate adenocarcinomas [39]. Here, TMPRSS2 is linked to prostate adenocarcinoma.